Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohong Han

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 26, 2015
[Current situations of targeted therapy in ALK-positive non-small cell lung cancer]Ningning Zhang, Xiaohong Han, Yuankai Shi
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[Colorectal cancer targeted therapy]Yinchen Shen, Yuankai Shi, Xiaohong Han
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[Advances on molecular targets for squamous cell lung cancer targeted therapy]Dan Tao, Yuankai Shi, Xiaohong Han
Frontiers in Immunology|December 12, 2022
Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapyLei Zhang, Yuankai Shi, Xiaohong Han
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 29, 2015
[The progress of diagnostic and prognostic molecular markers of lymphoma]Ming Zhang, Yuankai Shi, Xiaohong Han
Future Oncology (London, England)|November 16, 2021
The impact of the <i>ALK</i> fusion variant on clinical outcomes in <i>EML4-ALK</i> patients with NSCLC: a systematic review and meta-analysisShasha Wang, Rongrong Luo, Yuankai Shi, et al.
Computers in Biology and Medicine|October 15, 2022
Automatic classification of thyroid nodules in ultrasound images using a multi-task attention network guided by clinical knowledgePengju Deng, Xiaohong Han, Xi Wei, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 28, 2022
[MUC16: The Novel Target for Tumor Therapy]Ruyun Gao, Ning Lou, Xiaohong Han, et al.
Virology Journal|August 9, 2011
Sequence analysis reveals mosaic genome of Aichi virusXiaohong Han, Wen Zhang, Yanjun Xue, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005-2020): A systematic reviewHaizhu Chen, Yu Zhou, Xiaohong Han, et al.
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 26, 2015
[Current situations of targeted therapy in ALK-positive non-small cell lung cancer]Ningning Zhang, Xiaohong Han, Yuankai Shi
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[Colorectal cancer targeted therapy]Yinchen Shen, Yuankai Shi, Xiaohong Han
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[Advances on molecular targets for squamous cell lung cancer targeted therapy]Dan Tao, Yuankai Shi, Xiaohong Han
Frontiers in Immunology|December 12, 2022
Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapyLei Zhang, Yuankai Shi, Xiaohong Han
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 29, 2015
[The progress of diagnostic and prognostic molecular markers of lymphoma]Ming Zhang, Yuankai Shi, Xiaohong Han
Future Oncology (London, England)|November 16, 2021
The impact of the <i>ALK</i> fusion variant on clinical outcomes in <i>EML4-ALK</i> patients with NSCLC: a systematic review and meta-analysisShasha Wang, Rongrong Luo, Yuankai Shi, et al.
Computers in Biology and Medicine|October 15, 2022
Automatic classification of thyroid nodules in ultrasound images using a multi-task attention network guided by clinical knowledgePengju Deng, Xiaohong Han, Xi Wei, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 28, 2022
[MUC16: The Novel Target for Tumor Therapy]Ruyun Gao, Ning Lou, Xiaohong Han, et al.
Virology Journal|August 9, 2011
Sequence analysis reveals mosaic genome of Aichi virusXiaohong Han, Wen Zhang, Yanjun Xue, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005-2020): A systematic reviewHaizhu Chen, Yu Zhou, Xiaohong Han, et al.
Pageof 24